Abbott

Abbott

Life-changing health technologies in the area of diagnostics, medical devices, nutritionals and branded generic medicines. Learn more

Launch date
Employees
Market cap
AUD313.0b
Enterprise valuation
AUD324.6b (Public information from Sep 2024)
Lake Bluff Illinois (HQ)

Financials

Estimates*

Edit
Revenues, earnings & profits over time
USD2020202120222023202420252026
Revenues34.6b43.1b43.7b40.1b41.7b44.8b48.1b
% growth8 %24 %1 %(8 %)4 %7 %7 %
EBITDA7.6b10.7b10.7b10.6b10.7b11.6b12.9b
% EBITDA margin22 %25 %25 %26 %26 %26 %27 %
Profit4.5b7.1b6.9b5.7b5.8b6.8b7.8b
% profit margin13 %16 %16 %14 %14 %15 %16 %
EV / revenue5.8x5.8x4.5x5.0x4.9x4.5x4.1x
EV / EBITDA26.3x23.2x18.5x18.8x19.0x17.2x15.2x
R&D budget2.4b2.7b2.9b2.7b---
R&D % of revenue7 %6 %7 %7 %---

Source: Dealroom estimates

  • Edit
DateInvestorsAmountRound
-

N/A

-
N/A

N/A

IPO
N/A

$6.7m

Post IPO Debt
N/A

$100k

Post IPO Debt
Total Funding-

Recent News about Abbott

Edit
More about Abbottinfo icon
Edit

Abbott Laboratories is a global healthcare company dedicated to improving lives through innovative medical technologies and health solutions. The company operates in several key areas, including cardiovascular health, diabetes management, diagnostic testing, nutrition, and neuromodulation for chronic pain and movement disorders. Abbott's mission is to create life-changing technologies that are accessible and affordable, aiming to help people live their best lives.

Abbott serves a diverse range of clients, including hospitals, healthcare professionals, and patients. The company operates in the global healthcare market, which encompasses various sectors such as medical devices, diagnostics, and nutrition. Abbott's business model focuses on research and development to create advanced medical products and solutions that address critical health needs.

The company generates revenue through the sale of its medical devices, diagnostic tests, and nutritional products. For instance, Abbott's cardiovascular technologies help doctors manage heart health more effectively, while its diabetes care products allow patients to monitor their glucose levels accurately without painful fingersticks. In diagnostics, Abbott provides essential testing solutions that deliver timely information for better decision-making. Additionally, the company's neuromodulation products offer relief for chronic pain and movement disorders by targeting specific areas of the nervous system.

Abbott is also committed to sustainability, with a 2030 Sustainability Plan that prioritizes designing technologies for greater access and affordability. This commitment underscores the company's broader goal of making a positive impact on global health and well-being.

Keywords: healthcare, medical devices, diagnostics, cardiovascular, diabetes management, neuromodulation, chronic pain, nutrition, sustainability, innovation.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit
  • Edit
STARLIMS (Formerly Abbott Informatics)
BUYOUT by Francisco Partners Jul 2021
Visiogen
ACQUISITION by Abbott Sep 2009
OptiMedica
ACQUISITION by Abbott Jul 2013
Topera
ACQUISITION by Abbott Oct 2014
Ibis Biosciences
ACQUISITION by Abbott Dec 2008
Evalve
ACQUISITION by Abbott Sep 2009
Alere
ACQUISITION by Abbott Oct 2017
Tendyne Holdings
ACQUISITION by Abbott Jul 2015
Cardiovascular Systems
ACQUISITION by Abbott Feb 2023
View 14 more